Knivsta, Sweden

Lars-Olof Andersson

This inventor holds 2 USPTO granted patents. Top assignee: Kabivitrum Ab. Active years: 1988-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars-Olof Andersson. Retrieved from https://idiyas.com/inventor/lars-olof-andersson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1988-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Lars-Olof Andersson

Introduction

Lars-Olof Andersson is a notable inventor based in Knivsta, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for hemophilia. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from this condition.

Latest Patents

Andersson's latest patents focus on biologically active fragments of human antihemophilic factor. These patents detail novel, biologically active fragments, processes for their preparation, and pharmaceutical preparations containing them. The use of such fragments is aimed at treating patients suffering from hemophilia, showcasing his commitment to advancing medical science.

Career Highlights

Lars-Olof Andersson is associated with Kabivitrum AB, where he continues to innovate and develop new solutions in the field of biotechnology. His work is characterized by a dedication to improving patient outcomes through scientific research and development.

Collaborations

Andersson has collaborated with notable coworkers, including Nanna Forsman and Kerstin E. Larsen. These partnerships have likely contributed to the success of his projects and the advancement of their shared goals in biotechnology.

Conclusion

Lars-Olof Andersson's contributions to the field of biotechnology, particularly in the treatment of hemophilia, highlight his role as an influential inventor. His innovative patents and collaborations reflect a commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…